Lifetime management of severely calcified coronary lesions: the treatment algorithm focused on the shape of calcification.
Sakakura K, Jinnouchi H, Taniguchi Y, Yamamoto K, Fujita H.
Cardiovasc Interv Ther. 2023 Oct;38(4):375-380. doi: 10.1007/s12928-023-00950-x. Epub 2023 Aug 5.
Coronary Artery Bypass at a Drug-Eluting Resorbable Magnesium Scaffold Site in a Porcine Model.
Cohen JE, Garcia-Garcia HM, Hellinga D, Kolodgie F, Virmani R, Finn A, Waksman R.
Cardiovasc Revasc Med. 2022 Sep;42:109-113. doi: 10.1016/j.carrev.2022.02.026. Epub 2022 Feb 28.
Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study.
Ali ZA, Nef H, Escaned J, Werner N, Banning AP, Hill JM, De Bruyne B, Montorfano M, Lefevre T, Stone GW, Crowley A, Matsumura M, Maehara A, Lansky AJ, Fajadet J, Di Mario C.
Circ Cardiovasc Interv. 2019 Oct;12(10):e008434. doi: 10.1161/CIRCINTERVENTIONS.119.008434. Epub 2019 Sep 25.
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.
Hemetsberger R, Abdelghani M, Toelg R, Mankerious N, Allali A, Garcia-Garcia HM, Windecker S, Lefèvre T, Saito S, Slagboom T, Kandzari D, Koolen J, Waksman R, Richardt G.
J Am Heart Assoc. 2021 Jun 15;10(12):e019815. doi: 10.1161/JAHA.120.019815. Epub 2021 May 29.
Rotational atherectomy and new-generation drug-eluting stent implantation.
Hachinohe D, Kashima Y, Kanno D, Kobayashi K, Sugie T, Kaneko U, Tadano Y, Watanabe T, Shitan H, Fujita T.
Catheter Cardiovasc Interv. 2018 May 1;91(6):1026-1034. doi: 10.1002/ccd.27446. Epub 2017 Dec 5.
Sirolimus-eluting stent implantation for ostial right coronary artery lesions: five-year outcomes from the j-Cypher registry.
Ko E, Natsuaki M, Toyofuku M, Morimoto T, Matsumura Y, Oi M, Motohashi Y, Takahashi K, Kawase Y, Tanaka M, Kitada M, Yuzuki Y, Tamura T, Inoue K, Mitsudo K, Kimura T.
Cardiovasc Interv Ther. 2014 Jul;29(3):200-8. doi: 10.1007/s12928-013-0236-2. Epub 2014 Jan 5.
Target lesion calcification and risk of adverse outcomes in patients with drug-eluting stents. A meta-analysis.
Huang BT, Huang FY, Zuo ZL, Liu W, Huang KS, Liao YB, Wang PJ, Peng Y, Zhang C, Zhao ZG, Huang DJ, Chen M.
Herz. 2015 Dec;40(8):1097-106. doi: 10.1007/s00059-015-4324-1. Epub 2015 Jun 27.
Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: impact on healing.
Torii S, Jinnouchi H, Sakamoto A, Mori H, Park J, Amoa FC, Sawan M, Sato Y, Cornelissen A, Kuntz SH, Kutyna M, Paek KH, Fernandez R, Braumann R, Mont EK, Surve D, Romero ME, Kolodgie FD, Virmani R, Finn AV.
Eur Heart J. 2020 Feb 1;41(6):786-796. doi: 10.1093/eurheartj/ehz850.
Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms.
Scarparo P, Schermers T, Improta R, Kardys I, Wilschut J, Daemen J, Nuis RJ, Den Dekker WK, Van Mieghem NM, Diletti R.
Catheter Cardiovasc Interv. 2023 Sep;102(3):451-463. doi: 10.1002/ccd.30774. Epub 2023 Aug 1.
High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
Abdel-Wahab M, Toelg R, Byrne RA, Geist V, El-Mawardy M, Allali A, Rheude T, Robinson DR, Abdelghani M, Sulimov DS, Kastrati A, Richardt G.
Circ Cardiovasc Interv. 2018 Oct;11(10):e007415. doi: 10.1161/CIRCINTERVENTIONS.118.007415.
